Zota Health Care Limited

NSE ZOTA.NS

Zota Health Care Limited EPS (Diluted) for the year ending March 31, 2024: USD -0.07

Zota Health Care Limited EPS (Diluted) is USD -0.07 for the year ending March 31, 2024, a -138.81% change year over year. EPS (Diluted) reflects the company's earnings per share adjusted for the potential dilution that could occur if all convertible securities were converted to common stock, providing a more conservative profitability measure.

Zota Health Care Limited EPS (Diluted) for the year ending March 31, 2023 was USD -0.03, a -159.09% change year over year.
Zota Health Care Limited EPS (Diluted) for the year ending March 31, 2022 was USD 0.05, a 4,156.80% change year over year.
Zota Health Care Limited EPS (Diluted) for the year ending March 31, 2021 was USD -0.00, a -107.82% change year over year.
Zota Health Care Limited EPS (Diluted) for the year ending March 31, 2020 was USD 0.01, a -54.30% change year over year.

Key data

Date	EPS (Diluted)	Shares (Diluted, Weighted)	Shares (Basic, Weighted)	Revenue

NSE: ZOTA.NS

Zota Health Care Limited

CEO	Dr. Sujit Paul
IPO Date	May 10, 2017
Location	India
Headquarters	Zota House
Employees	445
Sector	Healthcare
Industries Drugstores & Retail Pharmacies Cosmetics Eyewear Personal Care Pharmaceuticals Specialty Retail

Description

Zota Health Care Limited develops, manufactures, and markets pharmaceutical products in India. It offers generic drugs, over-the-counter products, ayurvedic products, and nutraceutical products. The company provides various medicines for chronic illnesses, including heart disease, diabetes, thyroid, and others. As of March 31, 2021, it operated 591 retail stores under the DAVAINDIA name in 24 states of India. The company was founded in 1995 and is headquartered in Surat, India.

Key trends

Past 5 years